Primary immune thrombocytopenia is a primary disease associated with an abnormal autoimmune response. Adults have a longer course of the disease and may not be completely cured; children have a better prognosis than adults, but treatment also varies from person to person.
Primary immune thrombocytopenia is related to abnormalities in the immune system, with the body becoming immune intolerant to its own antigens. Typical clinical manifestations of the disease are a marked decrease in peripheral platelets at the onset of the disease, accompanied by ecchymosis of the skin and mucous membranes, etc. In adults, the disease is more insidious.
In adults, the onset of the disease is more insidious, with no obvious history of infection or other diseases, and the symptoms can be relieved after treatment, but the course of the disease is mostly chronic and may not be completely cured.
In children, the course of the disease is usually shorter, with 80% of cases resolving spontaneously within 6 months.
In the presence of immune thrombocytopenia, it is advisable to visit a hospital and seek treatment promptly to avoid delays.